Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability

• Main Authors: Tanin Intragumtornchai, Udomsak Bunworasate, Noppadol Siritanaratkul, Archrob Khuhapinant, Weerasak Nawarawong, Lalita Norasetthada, Arnuparp Lekhakula, Pairaya Rujirojindakul, Chittima Sirijerachai, Kanjana Chansung, Tawatchai Suwanban, Suporn Chuncharunee, Pimjai Niparuck, Somchai Wongkhantee, Wichean Mongkonsritragoon, Tontanai Numbenjapon
• 格式: 雜誌
• 出版: 2018
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870893023&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/48352
• 機構: Chiang Mai University

The impact of health insurance with inequitable rituximab coverage on the survival of patients with diffuse large B-cell lymphoma (DLBCL) has never been reported. We conducted a nationwide multicenter analysis on the outcome of 553 adult patients consecutively diagnosed with DLBCL between July 2003...